, ,
Presentations this author is a contributor to:
Liraglutide achieves HbA1c targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline HbA1c <8.0% (#259)
1:30 PM
Stephen Colagiuri
ADS Clinical Poster Session
Lower Rates in Overall and Nocturnal Hypoglycemia of Insulin Degludec vs. Insulin Glargine with Treatment Intensification in T2DM in Moderately Good Control (A1c 7.5–8.5%) at Baseline: A Meta-Analysis (#260)
1:30 PM
Stephen Colagiuri
ADS Clinical Poster Session
Identifying predictors of response to liraglutide in type 2 diabetes using recursive partitioning analysis (#47)
12:15 PM
Stephen Colagiuri
ADS Clinical Orals - Treatment options
Management of diabetes in elderly/pall care (#72)
8:30 AM
Stephen Colagiuri
ADS Clinical Symposium - Management of diabetes in the elderly/palliative care